keyword
https://read.qxmd.com/read/38633972/osteosarcoma-in-a-teenage-athlete-with-a-swollen-knee-joint
#1
Amresh Gul, Zahid Khan
Osteosarcoma is a malignant mesenchymal tumour. This primarily manifests in the formation of immature osteoid cells by tumour cells. Osteosarcoma is the most common primary bone tumour in children and adolescents. It tends to occur in the metaphysis of long shafts, shows osteoblastic differentiation, and produces malignant osteoid material. We present the case of a 17-year-old male who presented to our clinic who had left knee pain for a few days. An initial radiograph of the knee joint revealed a lytic lesion in the proximal tibia and further imaging was advised...
March 2024: Curēus
https://read.qxmd.com/read/38621306/metastatic-intradural-primary-spinal-osteosarcoma-illustrative-case
#2
JOURNAL ARTICLE
Shreyas Thiruvengadam, Mark Lam, Stephen Honeybul
BACKGROUND: Osteosarcomas are a common primary bone neoplasm among adolescents but represent 0.2% of all malignancies with an incidence of two to four cases per million persons annually worldwide. Although known to have significant metastatic potential, its rare incidence, treatment resistance, and poor prognosis have rendered it a poorly understood and infrequently documented pathology. OBSERVATIONS: Herein the authors present the first documented case of lumbosacral intradural metastasis of a primary osteosarcoma in a young patient, possibly via intradural dissemination following pinhole durotomy in a prior thoracic surgery...
April 15, 2024: J Neurosurg Case Lessons
https://read.qxmd.com/read/38612805/proteomic-analyses-reveal-the-role-of-alpha-2-macroglobulin-in-canine-osteosarcoma-cell-migration
#3
JOURNAL ARTICLE
Sylwia S Wilk, Katarzyna Michalak, Ewelina P Owczarek, Stanisław Winiarczyk, Katarzyna A Zabielska-Koczywąs
Canine osteosarcoma (OSA) is an aggressive bone neoplasia with high metastatic potential. Metastasis is the main cause of death associated with OSA, and there is no current treatment available for metastatic disease. Proteomic analyses, including matrix-assisted laser desorption/ionisation-time of flight mass spectrometry (MALDI TOF/TOF MS), are widely used to select molecular targets and identify proteins that may play a key role in primary tumours and at various steps of the metastatic cascade. The main aim of this study was to identify proteins differently expressed in canine OSA cell lines with different malignancy phenotypes (OSCA-8 and OSCA-32) compared to canine osteoblasts (CnOb)...
April 3, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612399/vitexicarpin-induces-apoptosis-and-inhibits-metastatic-properties-via-the-akt-pras40-pathway-in-human-osteosarcoma
#4
JOURNAL ARTICLE
Hyung-Mun Yun, Hyun Sook Kwon, Joon Yeop Lee, Kyung-Ran Park
Osteosarcoma, which has poor prognosis after metastasis, is the most common type of bone cancer in children and adolescents. Therefore, plant-derived bioactive compounds are being actively developed for cancer therapy. Artemisia apiacea Hance ex Walp. is a traditional medicinal plant native to Eastern Asia, including China, Japan, and Korea. Vitexicarpin (Vitex), derived from A. apiacea, has demonstrated analgesic, anti-inflammatory, antitumour, and immunoregulatory properties; however, there are no published studies on Vitex isolated from the aerial parts of A...
March 22, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38596830/extracellular-vesicles-from-highly-metastatic-osteosarcoma-cells-induce-pro-tumorigenic-macrophage-phenotypes
#5
JOURNAL ARTICLE
Katherine H Griffin, Rachel R Mizenko, Vishalakshi Arun, Randy P Carney, J Kent Leach
Metastasis is the principal factor in poor prognosis for individuals with osteosarcoma (OS). Understanding the events that lead to metastasis is critical to develop better interventions for this disease. Alveolar macrophages are potentially involved in priming the lung microenvironment for OS metastasis, yet the mechanisms involved in this process remain unclear. Since extracellular vesicles (EVs) are a known actor in primary tumor development, their potential role in OS metastagenesis through macrophage modulation is explored here...
April 10, 2024: Advanced biology
https://read.qxmd.com/read/38585233/mir-1246-promotes-osteosarcoma-cell-migration-via-namirna-enhancer-network-dependent-on-argonaute-2
#6
JOURNAL ARTICLE
Shuai Yang, Qingping Zou, Ying Liang, Dapeng Zhang, Lina Peng, Wei Li, Wenxuan Li, Mengxing Liu, Ying Tong, Lu Chen, Peng Xu, Zhicong Yang, Kaicheng Zhou, Jianru Xiao, Hailin Wang, Wenqiang Yu
High metastatic propensity of osteosarcoma leads to its therapeutic failure and poor prognosis. Although nuclear activation miRNAs (NamiRNAs) are reported to activate gene transcription via targeting enhancer and further promote tumor metastasis, it remains uncertain whether NamiRNAs regulate osteosarcoma metastasis and their exact mechanism. Here, we found that extracellular vesicles of the malignant osteosarcoma cells (143B) remarkably increased the migratory abilities of MNNG cells representing the benign osteosarcoma cells by two folds, which attributed to their high miR-1246 levels...
April 2024: MedComm
https://read.qxmd.com/read/38575425/sex-differences-in-osteosarcoma-survival-across-the-age-spectrum-a-national-cancer-database-analysis-2004-2016
#7
JOURNAL ARTICLE
Lindsay A Williams, Sofia Barragan, Zhanni Lu, Brenda J Weigel, Logan G Spector
BACKGROUND: Osteosarcoma displays a bimodal peak in incidence in adolescence and later adulthood. Males are more frequently diagnosed with osteosarcoma in both periods. Males have worse survival than females, which is generally poor at 30-70% 5-years post diagnosis, depending on age, but treatment received is often unaccounted for in survival analyses. METHODS: Therefore, we estimated sex differences in survival for children and adults stratifying by treatment received and other disease characteristics using the National Cancer Database (2004-2016, n=9017)...
April 3, 2024: Cancer Epidemiology
https://read.qxmd.com/read/38562379/single-nucleotide-variants-in-nuclear-pore-complex-disassembly-pathway-associated-with-poor-survival-in-osteosarcoma
#8
JOURNAL ARTICLE
James E Jacobs, Lara Davis, Shannon McWeeney
INTRODUCTION: The bone tumor, osteosarcoma, remains challenging to treat in children and young adults, especially when patients present with metastatic disease. Developing new therapies based on genomic data from sequencing projects has proven difficult given the lack of recurrent genetic lesions across tumors. MYC overexpression has been associated with poor outcomes in osteosarcoma. However, other genomic markers of disease severity are lacking. MATERIALS AND METHODS: We utilized whole genome sequencing of 106 tumors and matched normal controls in order to define genomic characteristics that correlate with overall survival...
2024: Frontiers in Genetics
https://read.qxmd.com/read/38554158/targeting-osteosarcoma-with-canine-b7-h3-car-t-cells-and-impact-of-cxcr2-co-expression-on-functional-activity
#9
JOURNAL ARTICLE
Jennifer W Cao, Jessica Lake, Renata Impastato, Lyndah Chow, Luisanny Perez, Laura Chubb, Jade Kurihara, Michael R Verneris, Steven Dow
The use of large animal spontaneous models of solid cancers, such as dogs with osteosarcoma (OS), can help develop new cancer immunotherapy approaches, including chimeric antigen receptor (CAR) T cells. The goal of the present study was to generate canine CAR T cells targeting the B7-H3 (CD276) co-stimulatory molecule overexpressed by several solid cancers, including OS in both humans and dogs, and to assess their ability to recognize B7-H3 expressed by canine OS cell lines or by canine tumors in xenograft models...
March 30, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38551765/osteosarcoma-cells-exhibit-functional-interactions-with-stromal-cells-fostering-a-lung-microenvironment-conducive-to-the-establishment-of-metastatic-tumor-cells
#10
JOURNAL ARTICLE
Matías J P Valenzuela Alvarez, Luciana M Gutierrez, Juan M Bayo, María J Cantero, Mariana G Garcia, Marcela F Bolontrade
BACKGROUND: Osteosarcoma (OS) stands out as the most common bone tumor, with approximately 20% of the patients receiving a diagnosis of metastatic OS at their initial assessment. A significant challenge lies in the frequent existence of undetected metastases during the initial diagnosis. Mesenchymal stem cells (MSCs) possess unique abilities that facilitate tumor growth, and their interaction with OS cells is crucial for metastatic spread. METHODS AND RESULTS: We demonstrated that, in vitro, MSCs exhibited a heightened migration response toward the secretome of non-metastatic OS cells...
March 29, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38549062/patterns-and-treatment-outcomes-of-primary-bone-tumors-in-children-treated-at-tertiary-referral-hospital-ethiopia
#11
JOURNAL ARTICLE
Temesgen Lingerih, Sewagegn Yeshiwas, Abdulkadir Mohamedsaid, Gashaw Arega
BACKGROUND: Bone tumors account for approximately 6% of all cancers in children. Malignant bone tumors, commonly occurring in children and adolescents, are associated with high mortality and morbidity. The overall survival of children with primary malignant bone tumors is affected by the stage of disease, time of diagnosis, and treatment response. Despite advanced treatment modalities with chemotherapy, surgery, and radiotherapy, bone tumor is the third leading cause of death in children with malignancy...
March 28, 2024: BMC Cancer
https://read.qxmd.com/read/38546286/exploring-gene-biomarkers-and-targeted-drugs-for-ferroptosis-and-cuproptosis-in-osteosarcoma-a-bioinformatic-approach
#12
JOURNAL ARTICLE
Yingnan Ji, Lv Liu, Yu Liu, Yudong Ma, Zhenhua Ji, Xiaodan Wu, Qi Zhu
Osteosarcoma predominantly affects adolescents and young adults and is characterized as a malignant bone tumor. In recent decades, substantial advancements have been achieved in both diagnosing and treating osteosarcoma. Resulting in enhanced survival rates. Despite these advancements, the intricate relationship between ferroptosis and cuproptosis genes in osteosarcoma remains inadequately understood. Leveraging TARGET and GEO datasets, we conducted Cox regression analysis to select prognostic genes from a cohort of 71 candidates...
March 28, 2024: Environmental Toxicology
https://read.qxmd.com/read/38545589/forequarter-amputation-for-malignant-tumours-tale-of-sustained-relevance-or-telltale-sign-of-doom
#13
JOURNAL ARTICLE
Mudasir Bashir Dar, Gaurav Das
Forequarter amputation (interscapulothoracic amputation) includes surgical removal of an upper limb and the shoulder girdle, including the scapula and a portion of the clavicle. We aim to report about our recent experience of having to resort to this mutilating surgery and the clinicopathological variables in that context. The study was done at a cancer centre in Northeast India. It was an ambispective study design, where the patient cohort who underwent FQA was identified retrospectively from the operative register of major surgeries for the time period 1st June 2020 to 31st May 2022 (24 months), and these patients were followed up prospectively from 1st June 2022 to 31st May 2023 (1 year)...
March 2024: Indian Journal of Surgical Oncology
https://read.qxmd.com/read/38545575/prognostic-factors-influencing-survival-and-oncological-outcome-in-patients-with-parosteal-osteosarcoma
#14
JOURNAL ARTICLE
Buğra Alpan, Osman Emre Aycan, Serkan Bayram, Emre Özmen, Natig Valiyev, Harzem Özger, Levent Eralp
This study aimed to evaluate the significance of radiological (magnetic resonance imaging [MRI]) findings, surgical, and previous interventions on prognosis with oncological and functional outcome in patients with parosteal osteosarcoma (POS). Twenty-seven patients (8 male/19 female) who were operated with the diagnosis of primary POS in our institution were retrospectively reviewed. The epidemiological data, biopsy method, misdiagnosis/improper interventions, and delay in diagnosis were noted. The lesions' maximum circumferential extension, maximum longitudinal extension, intramedullary involvement, and neurovascular extensions in MRI sections were evaluated, and the resection type (segmental intraarticular/segmental intercalary/hemicortical), reconstruction type (biologic/non-biologic), and surgical margins were noted...
March 2024: Indian Journal of Surgical Oncology
https://read.qxmd.com/read/38545002/effects-of-combined-sintilimab-and-chemotherapy-on-progression-free-survival-and-overall-survival-in-osteosarcoma-patients-with-metastasis
#15
JOURNAL ARTICLE
Fan Li, De-Bao Zhang, Yue Ma, Yang Song, Xian-Liang Duan
OBJECTIVE: To explore the safety and efficacy of metastatic osteosarcoma treatment with combined sintilimab injection and chemotherapy. METHODS: We performed a retrospective analysis of 32 patients with metastatic osteosarcoma admitted to the Affiliated Hospital of Beihua University between January 2019 and June 2020. The sample was divided into an observation group, treated with sintilimab injection combined with chemotherapy (n= 16) and a control group, treated with chemotherapy (n = 16)...
2024: Pakistan Journal of Medical Sciences Quarterly
https://read.qxmd.com/read/38534381/protein-stability-regulation-in-osteosarcoma-the-ubiquitin-like-modifications-and-glycosylation-as-mediators-of-tumor-growth-and-as-targets-for-therapy
#16
REVIEW
Jacopo Di Gregorio, Laura Di Giuseppe, Sara Terreri, Michela Rossi, Giulia Battafarano, Olivia Pagliarosi, Vincenzo Flati, Andrea Del Fattore
The identification of new therapeutic targets and the development of innovative therapeutic approaches are the most important challenges for osteosarcoma treatment. In fact, despite being relatively rare, recurrence and metastatic potential, particularly to the lungs, make osteosarcoma a deadly form of cancer. In fact, although current treatments, including surgery and chemotherapy, have improved survival rates, the disease's recurrence and metastasis are still unresolved complications. Insights for analyzing the still unclear molecular mechanisms of osteosarcoma development, and for finding new therapeutic targets, may arise from the study of post-translational protein modifications...
March 18, 2024: Cells
https://read.qxmd.com/read/38532886/the-rna-binding-proteins-larp4a-and-larp4b-promote-sarcoma-and-carcinoma-growth-and-metastasis
#17
JOURNAL ARTICLE
Jennifer C Coleman, Luke Tattersall, Val Yianni, Laura Knight, Hongqiang Yu, Sadie R Hallett, Philip Johnson, Ana J Caetano, Charlie Cosstick, Anne J Ridley, Alison Gartland, Maria R Conte, Agamemnon E Grigoriadis
RNA-binding proteins (RBPs) are emerging as important regulators of cancer pathogenesis. We reveal that the RBPs LARP4A and LARP4B are differentially overexpressed in osteosarcoma and osteosarcoma lung metastases, as well as in prostate cancer. Depletion of LARP4A and LARP4B reduced tumor growth and metastatic spread in xenografts, as well as inhibiting cell proliferation, motility, and migration. Transcriptomic profiling and high-content multiparametric analyses unveiled a central role for LARP4B, but not LARP4A, in regulating cell cycle progression in osteosarcoma and prostate cancer cells, potentially through modulating key cell cycle proteins such as Cyclins B1 and E2, Aurora B, and E2F1...
April 19, 2024: IScience
https://read.qxmd.com/read/38527252/accelerating-cellular-uptake-with-unnatural-amino-acid-for-inhibiting-immunosuppressive-cancer-cells
#18
JOURNAL ARTICLE
Meihui Yi, Gabriel Ashton-Rickardt, Weiyi Tan, Zhiyu Liu, Hongjian He, Jer-Tsong Hsieh, Bing Xu
Targeting immunosuppressive metastatic cancer cells is a key challenge in therapy. We recently have shown that a rigid-rod aromatic, pBP-NBD, that responds to enzymes and kill immunosuppressive metastatic osteosarcoma (mOS) and castration resistant prostate cancer (CRPC) cells in mimetic bone microenvironment. However, pBP-NBD demonstrated moderate efficacy against CRPC cells. To enhance activity, we incorporated the unnatural amino acid L- or D-4,4'-biphenylalanine (L- or D-BiP) into pBP-NBD, drastically increasing cellular uptake and CRPC inhibition...
March 25, 2024: Chemistry: a European Journal
https://read.qxmd.com/read/38526643/investigation-of-cellular-communication-and-signaling-pathways-in-tumor-microenvironment-for-high-tp53-expressing-osteosarcoma-cells-through-single-cell-rna-sequencing
#19
JOURNAL ARTICLE
Kai Xiong, Yuqi Fang, Boyuan Qiu, Chaotao Chen, Nanchang Huang, Feiyuan Liang, Chuangming Huang, Tiantian Lu, Li Zheng, Jinmin Zhao, Bo Zhu
Osteosarcoma (OS) stands as the most prevalent primary bone cancer in children and adolescents, and its limited treatment options often result in unsatisfactory outcomes, particularly for metastatic cases. The tumor microenvironment (TME) has been recognized as a crucial determinant in OS progression. However, the intercellular dynamics between high TP53-expressing OS cells and neighboring cell types within the TME are yet to be thoroughly understood. In our study, we harnessed the single-cell RNA sequencing (scRNA-seq) technology in combination with the computational tool-Cellchat, aiming to elucidate the intercellular communication networks present within OS...
March 25, 2024: Medical Oncology
https://read.qxmd.com/read/38513152/intercalary-resection-of-the-tibia-for-primary-bone-tumors-are-vascularized-fibula-autografts-with-or-without-allografts-a-durable-reconstruction
#20
JOURNAL ARTICLE
Domenico Andrea Campanacci, Roberto Scanferla, Mariagrazia Marsico, Federico Scolari, Guido Scoccianti, Giovanni Beltrami, Luca Delcroix, Marco Innocenti, Rodolfo Capanna
BACKGROUND: Reconstruction with vascularized fibula grafts (VFG) after intercalary resection of sarcoma may offer longevity by providing early graft-host union and fracture healing. The ability of the fibula to hypertrophy under mechanical stress, as well as vascularized bone in the area, may also be advantageous, given that soft tissues may be compromised because of resection, chemotherapy, or radiation therapy. VFG with a massive allograft combines the primary mechanical stability of the graft with the biological potential of the vascularized fibula; however, complications and the durability of this combined reconstruction are not well described...
March 21, 2024: Clinical Orthopaedics and related Research
keyword
keyword
162321
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.